首页> 外文期刊>BMC Public Health >Cannabis use and the risk of tuberculosis: a systematic review
【24h】

Cannabis use and the risk of tuberculosis: a systematic review

机译:大麻使用和结核病的风险:系统审查

获取原文
           

摘要

Cannabis has been identified as a possible risk factor in some tuberculosis (TB) outbreaks. As the most widely used (largely) illegal substance in Western countries this may be an important public health concern. We aim to systematically review the evidence on the association between cannabis use and TB (latent infection and active disease) to inform ongoing and future TB prevention and control strategies. We conducted a systematic review. We searched Ovid Medline, Embase and PsycInfo, together with the World Health Organization website and Google Scholar, for all years to January 2018. Reference lists and conference abstracts were hand-searched, a forward citation search was conducted on the Web of Science, and experts were contacted. Two authors independently screened studies for inclusion, extracted data and assessed risk of bias using an adapted version of ROBINS-I ("Risk of Bias in Non-randomised Studies - of Interventions"). Data were narratively synthesised. Of 377 records identified, 11 studies were eligible. Study designs were heterogeneous. Six studies utilised a relevant comparator group. Four of these investigated the association between cannabis use and latent TB infection; all provided some evidence of an association, although only two of these had adjusted for confounders. The remaining two comparator studies investigated the association between cannabis use and active TB disease; neither found evidence of an association after adjusting for confounding. All six studies were at "Serious" risk of bias. The five studies which did not utilise a relevant comparator group were all indicative of TB outbreaks occurring among cannabis users, but the quality of the evidence was very weak. Evidence for an association between cannabis use and TB acquisition is weak. The topic warrants further robust primary research including the collection of consistent and accurate exposure information, including cannabis use practices, dose and frequency, and adjustment for confounders.
机译:大麻已被鉴定为某些结核病(TB)爆发的可能危险因素。作为西方国家最广泛使用的(主要)非法物质,这可能是一个重要的公共卫生问题。我们的目标是系统地审查关于大麻使用与结核病(潜在感染和活跃病)之间的关联的证据,以告知正在进行的和未来的TB预防和控制策略。我们进行了系统审查。我们将Ovid Medline,Embase和Psycinfo与世界卫生组织网站和Google Scholar一起搜索,全球卫生组织网站和谷歌学者持续到2018年1月。参考清单和会议摘要被手动搜查,在科学网上进行了向前引用搜索,专家接触。两位作者独立筛查了纳入,提取数据和使用适应的知更鸟类(非随机研究中的偏见风险 - 干预措施的偏差的偏倚风险)。数据界定合成。确定了377条记录,11项研究有资格。研究设计是异质的。六项研究利用相关的比较组。其中四个研究了大麻使用和潜伏结核病感染之间的关联;所有这些都提供了一份协会的证据,虽然只有其中只有两个调整了混杂者。其余的两种比较器研究研究了大麻使用和活性TB疾病之间的关联;在调整混淆后既没有发现关联的证据。所有六项研究都处于“严重”的偏见风险。未使用相关比较群的五项研究均表明在大麻用户中发生的结核病爆发,但证据的质量非常弱。大麻使用和结核病习得之间关联的证据很弱。该主题认证进一步强大的主要研究,包括集合一致和准确的曝光信息,包括大麻使用实践,剂量和频率,以及对混凝剂的调整。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号